| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nanoparticles | 19 | 2024 | 289 | 6.390 |
Why?
|
| Photochemotherapy | 7 | 2022 | 44 | 3.560 |
Why?
|
| Heteroptera | 5 | 2024 | 17 | 3.150 |
Why?
|
| Neoplasms | 16 | 2024 | 3035 | 2.850 |
Why?
|
| Photosensitizing Agents | 5 | 2021 | 39 | 2.570 |
Why?
|
| Nanostructures | 8 | 2024 | 65 | 2.360 |
Why?
|
| Mammary Glands, Animal | 10 | 2025 | 479 | 2.200 |
Why?
|
| Mammary Neoplasms, Experimental | 6 | 2025 | 246 | 2.010 |
Why?
|
| Antineoplastic Agents | 11 | 2021 | 1854 | 1.990 |
Why?
|
| Hydrogen Peroxide | 7 | 2023 | 131 | 1.880 |
Why?
|
| Ferrous Compounds | 3 | 2021 | 10 | 1.550 |
Why?
|
| Animals | 64 | 2025 | 36521 | 1.550 |
Why?
|
| Metal-Organic Frameworks | 2 | 2021 | 5 | 1.460 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2024 | 3868 | 1.410 |
Why?
|
| Zeolites | 2 | 2021 | 3 | 1.410 |
Why?
|
| Mice | 46 | 2025 | 19045 | 1.370 |
Why?
|
| Tumor Microenvironment | 7 | 2023 | 700 | 1.360 |
Why?
|
| Skin Neoplasms | 5 | 2023 | 907 | 1.310 |
Why?
|
| Hydroxyl Radical | 5 | 2023 | 13 | 1.290 |
Why?
|
| Breast Neoplasms | 13 | 2025 | 2771 | 1.290 |
Why?
|
| Metal Nanoparticles | 4 | 2024 | 59 | 1.240 |
Why?
|
| Iron | 3 | 2021 | 305 | 1.230 |
Why?
|
| Cell Line, Tumor | 21 | 2024 | 3800 | 1.230 |
Why?
|
| Phylogeny | 5 | 2024 | 781 | 1.220 |
Why?
|
| RNA, Long Noncoding | 2 | 2022 | 248 | 1.130 |
Why?
|
| Phylogeography | 2 | 2024 | 19 | 1.100 |
Why?
|
| Magnesium | 2 | 2024 | 127 | 1.080 |
Why?
|
| Climate Change | 2 | 2024 | 62 | 1.030 |
Why?
|
| Gadolinium | 5 | 2020 | 117 | 1.020 |
Why?
|
| Cerium | 3 | 2024 | 3 | 0.980 |
Why?
|
| Cellular Senescence | 3 | 2024 | 201 | 0.960 |
Why?
|
| Disease Models, Animal | 8 | 2025 | 4802 | 0.920 |
Why?
|
| Free Radicals | 2 | 2024 | 35 | 0.910 |
Why?
|
| Alginates | 1 | 2024 | 25 | 0.900 |
Why?
|
| Gold | 1 | 2024 | 57 | 0.890 |
Why?
|
| Energy Transfer | 2 | 2024 | 18 | 0.880 |
Why?
|
| Melanoma, Experimental | 1 | 2024 | 38 | 0.880 |
Why?
|
| Cancer Pain | 1 | 2024 | 28 | 0.880 |
Why?
|
| Optogenetics | 1 | 2024 | 76 | 0.870 |
Why?
|
| TRPV Cation Channels | 1 | 2024 | 46 | 0.870 |
Why?
|
| Endopeptidases | 1 | 2024 | 119 | 0.870 |
Why?
|
| Tyrosine | 1 | 2024 | 157 | 0.860 |
Why?
|
| Zinc | 1 | 2024 | 143 | 0.860 |
Why?
|
| Epithelial Cells | 8 | 2024 | 937 | 0.850 |
Why?
|
| Carbon | 1 | 2024 | 98 | 0.850 |
Why?
|
| Biodiversity | 1 | 2024 | 89 | 0.850 |
Why?
|
| Genetic Vectors | 4 | 2020 | 967 | 0.840 |
Why?
|
| Hydrogels | 1 | 2024 | 109 | 0.840 |
Why?
|
| Dopaminergic Neurons | 1 | 2024 | 53 | 0.830 |
Why?
|
| Liver Neoplasms | 3 | 2023 | 1416 | 0.830 |
Why?
|
| Cranial Irradiation | 1 | 2024 | 72 | 0.830 |
Why?
|
| Hemiptera | 1 | 2023 | 19 | 0.820 |
Why?
|
| NF-kappa B | 2 | 2024 | 483 | 0.820 |
Why?
|
| Glutathione | 4 | 2023 | 201 | 0.810 |
Why?
|
| Mammary Neoplasms, Animal | 4 | 2018 | 142 | 0.790 |
Why?
|
| Keloid | 1 | 2022 | 11 | 0.790 |
Why?
|
| Cysteine | 2 | 2020 | 143 | 0.790 |
Why?
|
| Apoptosis | 9 | 2024 | 1945 | 0.780 |
Why?
|
| Stem Cells | 4 | 2021 | 754 | 0.770 |
Why?
|
| Carcinogenesis | 6 | 2021 | 363 | 0.770 |
Why?
|
| Wound Infection | 1 | 2022 | 57 | 0.770 |
Why?
|
| Hidradenitis Suppurativa | 1 | 2022 | 6 | 0.770 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2023 | 131 | 0.760 |
Why?
|
| Precancerous Conditions | 3 | 2023 | 288 | 0.760 |
Why?
|
| Humans | 64 | 2025 | 134196 | 0.750 |
Why?
|
| Genome, Mitochondrial | 1 | 2022 | 34 | 0.750 |
Why?
|
| Oncolytic Viruses | 1 | 2022 | 76 | 0.740 |
Why?
|
| Pseudopodia | 1 | 2021 | 9 | 0.740 |
Why?
|
| Oncolytic Virotherapy | 1 | 2022 | 89 | 0.720 |
Why?
|
| Keratosis, Actinic | 1 | 2021 | 14 | 0.720 |
Why?
|
| Ferric Compounds | 2 | 2021 | 41 | 0.720 |
Why?
|
| Melanoma | 4 | 2024 | 969 | 0.720 |
Why?
|
| Autophagy | 2 | 2023 | 429 | 0.710 |
Why?
|
| Platinum | 1 | 2021 | 13 | 0.710 |
Why?
|
| Aminolevulinic Acid | 2 | 2021 | 12 | 0.710 |
Why?
|
| Cell Transformation, Neoplastic | 7 | 2018 | 645 | 0.710 |
Why?
|
| Cell Proliferation | 12 | 2024 | 2562 | 0.700 |
Why?
|
| Phosphotungstic Acid | 1 | 2020 | 2 | 0.690 |
Why?
|
| DNA, Catalytic | 1 | 2020 | 4 | 0.690 |
Why?
|
| Tumor Hypoxia | 1 | 2020 | 6 | 0.690 |
Why?
|
| Chlorine | 1 | 2020 | 17 | 0.690 |
Why?
|
| Gene Editing | 1 | 2023 | 213 | 0.680 |
Why?
|
| Glioma | 1 | 2025 | 535 | 0.670 |
Why?
|
| Thermography | 1 | 2020 | 12 | 0.670 |
Why?
|
| Neoplasms, Experimental | 3 | 2021 | 223 | 0.660 |
Why?
|
| Wnt Signaling Pathway | 3 | 2021 | 208 | 0.640 |
Why?
|
| Imidazoles | 1 | 2021 | 220 | 0.640 |
Why?
|
| Neurons | 3 | 2024 | 2051 | 0.630 |
Why?
|
| Cysteine-Rich Protein 61 | 1 | 2019 | 6 | 0.630 |
Why?
|
| China | 8 | 2024 | 296 | 0.620 |
Why?
|
| Oncogenes | 4 | 2024 | 181 | 0.620 |
Why?
|
| Mammary Tumor Virus, Mouse | 2 | 2018 | 108 | 0.620 |
Why?
|
| Lentivirus | 5 | 2020 | 86 | 0.610 |
Why?
|
| Transfection | 2 | 2020 | 1098 | 0.610 |
Why?
|
| Cisplatin | 2 | 2018 | 288 | 0.610 |
Why?
|
| Silver Compounds | 1 | 2018 | 7 | 0.600 |
Why?
|
| Brain Neoplasms | 3 | 2025 | 1406 | 0.590 |
Why?
|
| Insecta | 2 | 2022 | 67 | 0.580 |
Why?
|
| Prodrugs | 1 | 2018 | 64 | 0.580 |
Why?
|
| Membrane Proteins | 2 | 2024 | 1621 | 0.570 |
Why?
|
| Phosphates | 1 | 2018 | 121 | 0.570 |
Why?
|
| Oxygen | 2 | 2018 | 580 | 0.570 |
Why?
|
| DNA Helicases | 1 | 2019 | 253 | 0.550 |
Why?
|
| Drug Screening Assays, Antitumor | 4 | 2021 | 111 | 0.550 |
Why?
|
| Surface Properties | 4 | 2021 | 96 | 0.550 |
Why?
|
| Contrast Media | 4 | 2024 | 517 | 0.550 |
Why?
|
| Particle Size | 4 | 2021 | 148 | 0.540 |
Why?
|
| Rats | 5 | 2025 | 3876 | 0.540 |
Why?
|
| Spinal Cord Injuries | 1 | 2020 | 284 | 0.540 |
Why?
|
| Liver Cirrhosis | 1 | 2024 | 948 | 0.530 |
Why?
|
| Keratin-6 | 4 | 2016 | 13 | 0.520 |
Why?
|
| Receptor, ErbB-2 | 5 | 2016 | 562 | 0.520 |
Why?
|
| Nuclear Proteins | 3 | 2023 | 1351 | 0.510 |
Why?
|
| Catalysis | 3 | 2021 | 139 | 0.500 |
Why?
|
| Cell Survival | 6 | 2021 | 890 | 0.500 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2016 | 73 | 0.490 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2020 | 2137 | 0.490 |
Why?
|
| Reactive Oxygen Species | 4 | 2024 | 532 | 0.470 |
Why?
|
| Keratoderma, Palmoplantar | 2 | 2025 | 6 | 0.460 |
Why?
|
| RNA, Ribosomal | 2 | 2012 | 66 | 0.460 |
Why?
|
| Gene Transfer Techniques | 2 | 2023 | 362 | 0.460 |
Why?
|
| Serpins | 2 | 2025 | 34 | 0.460 |
Why?
|
| Silicon Dioxide | 4 | 2020 | 31 | 0.450 |
Why?
|
| X-Rays | 3 | 2021 | 30 | 0.450 |
Why?
|
| Micelles | 2 | 2024 | 21 | 0.450 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2023 | 1006 | 0.450 |
Why?
|
| Female | 39 | 2025 | 72037 | 0.430 |
Why?
|
| Boron Compounds | 2 | 2024 | 34 | 0.420 |
Why?
|
| Electrons | 3 | 2023 | 26 | 0.410 |
Why?
|
| RNA, Ribosomal, 28S | 1 | 2013 | 4 | 0.410 |
Why?
|
| Oxidative Stress | 3 | 2024 | 874 | 0.400 |
Why?
|
| Oxidation-Reduction | 4 | 2023 | 468 | 0.400 |
Why?
|
| Mice, Transgenic | 9 | 2023 | 2538 | 0.400 |
Why?
|
| Porphyrins | 2 | 2024 | 18 | 0.390 |
Why?
|
| DNA, Mitochondrial | 2 | 2024 | 244 | 0.390 |
Why?
|
| Wnt Proteins | 1 | 2013 | 226 | 0.390 |
Why?
|
| Archaea | 1 | 2012 | 13 | 0.380 |
Why?
|
| Eukaryota | 1 | 2012 | 25 | 0.370 |
Why?
|
| Prostatic Neoplasms | 1 | 2021 | 1626 | 0.370 |
Why?
|
| Infrared Rays | 2 | 2021 | 24 | 0.350 |
Why?
|
| Action Potentials | 2 | 2024 | 523 | 0.350 |
Why?
|
| Ribosomes | 1 | 2012 | 141 | 0.350 |
Why?
|
| CRISPR-Cas Systems | 2 | 2025 | 298 | 0.350 |
Why?
|
| Cell Nucleus | 2 | 2024 | 691 | 0.350 |
Why?
|
| Lung Neoplasms | 2 | 2018 | 1783 | 0.350 |
Why?
|
| Unemployment | 2 | 2021 | 23 | 0.350 |
Why?
|
| Bayes Theorem | 3 | 2022 | 315 | 0.340 |
Why?
|
| HeLa Cells | 4 | 2020 | 838 | 0.330 |
Why?
|
| Protein Array Analysis | 2 | 2022 | 107 | 0.330 |
Why?
|
| Retroviridae | 3 | 2023 | 198 | 0.320 |
Why?
|
| Magnetic Fields | 2 | 2021 | 7 | 0.320 |
Why?
|
| Transcription Factors | 1 | 2019 | 2735 | 0.300 |
Why?
|
| Phototherapy | 2 | 2022 | 39 | 0.290 |
Why?
|
| Cell Movement | 3 | 2022 | 920 | 0.290 |
Why?
|
| Methylmercury Compounds | 2 | 2018 | 5 | 0.280 |
Why?
|
| Seafood | 2 | 2018 | 10 | 0.280 |
Why?
|
| Mice, Nude | 5 | 2021 | 780 | 0.270 |
Why?
|
| Nanotechnology | 2 | 2020 | 51 | 0.260 |
Why?
|
| Quality of Life | 3 | 2022 | 2163 | 0.260 |
Why?
|
| Bone Neoplasms | 2 | 2024 | 447 | 0.260 |
Why?
|
| Mice, Inbred BALB C | 5 | 2021 | 1087 | 0.250 |
Why?
|
| Cell Plasticity | 2 | 2017 | 35 | 0.250 |
Why?
|
| Wound Healing | 2 | 2022 | 489 | 0.250 |
Why?
|
| Patient Satisfaction | 2 | 2022 | 490 | 0.250 |
Why?
|
| Epithelial-Mesenchymal Transition | 3 | 2019 | 249 | 0.250 |
Why?
|
| Janus Kinase 2 | 2 | 2018 | 134 | 0.240 |
Why?
|
| beta Catenin | 3 | 2023 | 232 | 0.230 |
Why?
|
| Genes, Reporter | 4 | 2020 | 399 | 0.230 |
Why?
|
| Glycolysis | 2 | 2024 | 173 | 0.230 |
Why?
|
| Polyethylene Glycols | 2 | 2018 | 257 | 0.230 |
Why?
|
| Gelatinases | 1 | 2024 | 16 | 0.230 |
Why?
|
| Borohydrides | 1 | 2024 | 3 | 0.230 |
Why?
|
| Heterocyclic Compounds | 1 | 2024 | 18 | 0.230 |
Why?
|
| Electrodes | 1 | 2024 | 91 | 0.230 |
Why?
|
| Liver | 2 | 2024 | 1876 | 0.220 |
Why?
|
| Melanins | 1 | 2024 | 20 | 0.220 |
Why?
|
| Animal Distribution | 1 | 2024 | 16 | 0.220 |
Why?
|
| Epidermis | 1 | 2024 | 66 | 0.220 |
Why?
|
| Organometallic Compounds | 1 | 2024 | 113 | 0.220 |
Why?
|
| Benzopyrans | 1 | 2024 | 21 | 0.220 |
Why?
|
| Analgesia | 1 | 2024 | 46 | 0.220 |
Why?
|
| Diffusion | 1 | 2024 | 58 | 0.220 |
Why?
|
| Light | 1 | 2024 | 183 | 0.220 |
Why?
|
| Motor Cortex | 1 | 2024 | 85 | 0.220 |
Why?
|
| Electricity | 1 | 2023 | 10 | 0.220 |
Why?
|
| Signal Transduction | 8 | 2024 | 4936 | 0.210 |
Why?
|
| Cysteine Endopeptidases | 1 | 2024 | 119 | 0.210 |
Why?
|
| Recombinational DNA Repair | 1 | 2023 | 19 | 0.210 |
Why?
|
| Analgesics | 1 | 2024 | 133 | 0.200 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2023 | 512 | 0.200 |
Why?
|
| Boron | 1 | 2022 | 3 | 0.200 |
Why?
|
| Basal Cell Nevus Syndrome | 1 | 2022 | 15 | 0.200 |
Why?
|
| Peptidoglycan | 1 | 2022 | 22 | 0.200 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2022 | 25 | 0.200 |
Why?
|
| Male | 13 | 2025 | 66197 | 0.200 |
Why?
|
| India | 1 | 2023 | 240 | 0.200 |
Why?
|
| Biological Evolution | 1 | 2024 | 256 | 0.200 |
Why?
|
| CD40 Ligand | 1 | 2022 | 65 | 0.200 |
Why?
|
| Neoptera | 1 | 2022 | 1 | 0.190 |
Why?
|
| Thiazoles | 1 | 2023 | 104 | 0.190 |
Why?
|
| Nanomedicine | 1 | 2022 | 26 | 0.190 |
Why?
|
| Microbubbles | 1 | 2022 | 12 | 0.190 |
Why?
|
| Fluorides | 2 | 2019 | 21 | 0.190 |
Why?
|
| Acoustics | 1 | 2022 | 23 | 0.190 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2023 | 259 | 0.190 |
Why?
|
| Endometrial Neoplasms | 1 | 2023 | 116 | 0.190 |
Why?
|
| Proteogenomics | 1 | 2023 | 110 | 0.190 |
Why?
|
| Nucleic Acid Conformation | 2 | 2013 | 202 | 0.190 |
Why?
|
| Electric Impedance | 1 | 2022 | 68 | 0.180 |
Why?
|
| Dermabrasion | 1 | 2021 | 4 | 0.180 |
Why?
|
| Mitochondria | 2 | 2024 | 758 | 0.180 |
Why?
|
| Drug Carriers | 2 | 2023 | 119 | 0.180 |
Why?
|
| Temperature | 2 | 2020 | 327 | 0.180 |
Why?
|
| Neoplastic Stem Cells | 2 | 2014 | 352 | 0.180 |
Why?
|
| Nitrosative Stress | 1 | 2021 | 3 | 0.180 |
Why?
|
| Hydrogenation | 1 | 2021 | 2 | 0.180 |
Why?
|
| Dietary Exposure | 2 | 2018 | 3 | 0.180 |
Why?
|
| Metformin | 1 | 2023 | 165 | 0.180 |
Why?
|
| Soil Pollutants | 1 | 2021 | 13 | 0.180 |
Why?
|
| Oryza | 1 | 2021 | 29 | 0.180 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2024 | 1308 | 0.180 |
Why?
|
| Metals, Heavy | 1 | 2021 | 23 | 0.180 |
Why?
|
| NAD | 1 | 2021 | 51 | 0.180 |
Why?
|
| Rats, Transgenic | 1 | 2020 | 15 | 0.170 |
Why?
|
| Lysosomes | 1 | 2023 | 266 | 0.170 |
Why?
|
| Lipopolysaccharides | 1 | 2022 | 319 | 0.170 |
Why?
|
| Fluorescence | 2 | 2018 | 103 | 0.170 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2022 | 353 | 0.170 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2020 | 26 | 0.170 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2020 | 11 | 0.170 |
Why?
|
| Silver | 1 | 2020 | 30 | 0.170 |
Why?
|
| STAT5 Transcription Factor | 2 | 2018 | 89 | 0.170 |
Why?
|
| Sodium Fluoride | 1 | 2020 | 11 | 0.170 |
Why?
|
| Mixed Function Oxygenases | 1 | 2020 | 36 | 0.170 |
Why?
|
| Neuroprotection | 1 | 2020 | 32 | 0.170 |
Why?
|
| Receptors, Estrogen | 2 | 2021 | 830 | 0.170 |
Why?
|
| Metallocenes | 1 | 2020 | 2 | 0.170 |
Why?
|
| Adenoviridae | 1 | 2023 | 607 | 0.160 |
Why?
|
| Fibroblasts | 2 | 2022 | 918 | 0.160 |
Why?
|
| Neoplasm Invasiveness | 2 | 2019 | 677 | 0.160 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2022 | 456 | 0.160 |
Why?
|
| Hyperthermia, Induced | 2 | 2018 | 58 | 0.160 |
Why?
|
| Antigens, Neoplasm | 1 | 2022 | 406 | 0.160 |
Why?
|
| HEK293 Cells | 2 | 2020 | 825 | 0.160 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2020 | 65 | 0.160 |
Why?
|
| Spine | 1 | 2020 | 147 | 0.160 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2020 | 72 | 0.160 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 2588 | 0.160 |
Why?
|
| Bismuth | 1 | 2020 | 83 | 0.160 |
Why?
|
| Calcium Carbonate | 1 | 2019 | 11 | 0.160 |
Why?
|
| Plasmids | 1 | 2020 | 531 | 0.160 |
Why?
|
| In Situ Hybridization | 1 | 2020 | 485 | 0.160 |
Why?
|
| Genomic Imprinting | 1 | 2020 | 130 | 0.160 |
Why?
|
| Theranostic Nanomedicine | 2 | 2017 | 7 | 0.160 |
Why?
|
| Transplantation, Heterologous | 1 | 2020 | 276 | 0.150 |
Why?
|
| Models, Genetic | 2 | 2013 | 790 | 0.150 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2020 | 152 | 0.150 |
Why?
|
| Polymers | 1 | 2020 | 118 | 0.150 |
Why?
|
| Sepsis | 1 | 2024 | 519 | 0.150 |
Why?
|
| Skin Diseases | 1 | 2020 | 135 | 0.150 |
Why?
|
| A549 Cells | 1 | 2018 | 49 | 0.150 |
Why?
|
| Computational Biology | 3 | 2014 | 890 | 0.150 |
Why?
|
| Ultrasonography | 1 | 2023 | 1004 | 0.150 |
Why?
|
| Juglandaceae | 1 | 2018 | 1 | 0.150 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2019 | 196 | 0.150 |
Why?
|
| Spleen | 1 | 2019 | 289 | 0.150 |
Why?
|
| Lithium Compounds | 1 | 2018 | 16 | 0.150 |
Why?
|
| Wnt1 Protein | 1 | 2018 | 74 | 0.150 |
Why?
|
| Bacteria | 1 | 2022 | 537 | 0.150 |
Why?
|
| Copper | 1 | 2018 | 75 | 0.150 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2019 | 307 | 0.150 |
Why?
|
| Diptera | 1 | 2018 | 27 | 0.150 |
Why?
|
| DNA | 1 | 2024 | 1685 | 0.140 |
Why?
|
| Histones | 1 | 2022 | 572 | 0.140 |
Why?
|
| Food Contamination | 1 | 2018 | 29 | 0.140 |
Why?
|
| Inflammation | 2 | 2024 | 1595 | 0.140 |
Why?
|
| Recovery of Function | 1 | 2020 | 464 | 0.140 |
Why?
|
| Sequence Analysis, DNA | 1 | 2024 | 1835 | 0.140 |
Why?
|
| Base Sequence | 2 | 2013 | 3180 | 0.140 |
Why?
|
| Cell Differentiation | 3 | 2024 | 2044 | 0.140 |
Why?
|
| Electrochemical Techniques | 1 | 2017 | 6 | 0.140 |
Why?
|
| Astacoidea | 1 | 2017 | 2 | 0.140 |
Why?
|
| Naphthoquinones | 1 | 2017 | 9 | 0.140 |
Why?
|
| Twist-Related Protein 1 | 1 | 2017 | 39 | 0.140 |
Why?
|
| Water Pollutants, Chemical | 1 | 2018 | 40 | 0.140 |
Why?
|
| DNA-Binding Proteins | 2 | 2020 | 2178 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 2 | 2024 | 4882 | 0.130 |
Why?
|
| Immunotherapy | 1 | 2022 | 750 | 0.130 |
Why?
|
| Middle Aged | 4 | 2024 | 29414 | 0.130 |
Why?
|
| Molecular Sequence Data | 2 | 2013 | 3978 | 0.130 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2023 | 2204 | 0.130 |
Why?
|
| Bone Density Conservation Agents | 1 | 2017 | 56 | 0.130 |
Why?
|
| Betacoronavirus | 1 | 2020 | 306 | 0.130 |
Why?
|
| Genetic Variation | 1 | 2024 | 1630 | 0.130 |
Why?
|
| Biosensing Techniques | 1 | 2017 | 69 | 0.130 |
Why?
|
| Muscles | 1 | 2017 | 280 | 0.130 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2017 | 111 | 0.130 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2020 | 625 | 0.130 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 2019 | 470 | 0.130 |
Why?
|
| Polylysine | 1 | 2016 | 11 | 0.130 |
Why?
|
| Iron Compounds | 1 | 2016 | 2 | 0.130 |
Why?
|
| Homeostasis | 1 | 2020 | 751 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 385 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 396 | 0.110 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2024 | 2949 | 0.110 |
Why?
|
| Colorectal Neoplasms | 1 | 2021 | 652 | 0.110 |
Why?
|
| Claudins | 1 | 2014 | 31 | 0.110 |
Why?
|
| Mammary Glands, Human | 1 | 2015 | 84 | 0.110 |
Why?
|
| Structure-Activity Relationship | 2 | 2016 | 610 | 0.110 |
Why?
|
| Disease-Free Survival | 1 | 2016 | 972 | 0.110 |
Why?
|
| Interleukin-8 | 1 | 2015 | 220 | 0.110 |
Why?
|
| GTP Phosphohydrolases | 1 | 2015 | 158 | 0.110 |
Why?
|
| Cells, Cultured | 2 | 2018 | 3180 | 0.110 |
Why?
|
| Tungsten Compounds | 1 | 2013 | 3 | 0.110 |
Why?
|
| MAP Kinase Kinase Kinase 3 | 1 | 2014 | 9 | 0.110 |
Why?
|
| Gene Expression Profiling | 2 | 2020 | 1922 | 0.110 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2020 | 867 | 0.110 |
Why?
|
| Blood Vessels | 1 | 2014 | 109 | 0.110 |
Why?
|
| Ischemia | 1 | 2017 | 386 | 0.110 |
Why?
|
| Anxiety | 1 | 2020 | 1005 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2013 | 39 | 0.100 |
Why?
|
| Retrospective Studies | 2 | 2022 | 17579 | 0.100 |
Why?
|
| Gene Amplification | 1 | 2014 | 247 | 0.100 |
Why?
|
| DNA, Ribosomal | 1 | 2013 | 57 | 0.100 |
Why?
|
| Phosphorylation | 4 | 2024 | 1713 | 0.100 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2012 | 12 | 0.100 |
Why?
|
| Adult | 5 | 2025 | 31948 | 0.100 |
Why?
|
| Glioblastoma | 2 | 2016 | 372 | 0.100 |
Why?
|
| STAT3 Transcription Factor | 1 | 2014 | 231 | 0.100 |
Why?
|
| Molecular Imaging | 1 | 2013 | 65 | 0.100 |
Why?
|
| Thyroid Hormones | 1 | 2012 | 71 | 0.100 |
Why?
|
| RNA, Ribosomal, 18S | 1 | 2012 | 19 | 0.100 |
Why?
|
| Peptidyl Transferases | 1 | 2012 | 7 | 0.090 |
Why?
|
| Contig Mapping | 1 | 2012 | 56 | 0.090 |
Why?
|
| Nitric Oxide | 1 | 2015 | 487 | 0.090 |
Why?
|
| Conserved Sequence | 1 | 2013 | 300 | 0.090 |
Why?
|
| Likelihood Functions | 1 | 2012 | 122 | 0.090 |
Why?
|
| Base Pairing | 1 | 2012 | 43 | 0.090 |
Why?
|
| Monte Carlo Method | 1 | 2012 | 102 | 0.090 |
Why?
|
| Avian Leukosis Virus | 1 | 2011 | 14 | 0.090 |
Why?
|
| Biomarkers, Tumor | 1 | 2020 | 1721 | 0.090 |
Why?
|
| Kidney Neoplasms | 1 | 2016 | 462 | 0.090 |
Why?
|
| Depression | 1 | 2020 | 1365 | 0.090 |
Why?
|
| Sequence Alignment | 1 | 2013 | 633 | 0.090 |
Why?
|
| ErbB Receptors | 1 | 2012 | 303 | 0.090 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2014 | 277 | 0.090 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2014 | 795 | 0.080 |
Why?
|
| I-kappa B Kinase | 2 | 2024 | 62 | 0.080 |
Why?
|
| Chromatin | 2 | 2023 | 617 | 0.080 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2012 | 440 | 0.080 |
Why?
|
| Binding Sites | 1 | 2012 | 1386 | 0.070 |
Why?
|
| Neoplasm Transplantation | 3 | 2014 | 399 | 0.070 |
Why?
|
| Mice, Knockout | 4 | 2024 | 4012 | 0.070 |
Why?
|
| Evolution, Molecular | 1 | 2012 | 710 | 0.070 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2008 | 88 | 0.070 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2013 | 830 | 0.070 |
Why?
|
| Brain | 2 | 2017 | 3226 | 0.070 |
Why?
|
| Treatment Outcome | 2 | 2021 | 13103 | 0.070 |
Why?
|
| Carrier Proteins | 1 | 2012 | 1075 | 0.070 |
Why?
|
| Software | 1 | 2012 | 736 | 0.070 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2010 | 510 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 1070 | 0.060 |
Why?
|
| Combined Modality Therapy | 2 | 2022 | 1312 | 0.060 |
Why?
|
| DNA Damage | 1 | 2010 | 547 | 0.060 |
Why?
|
| Keratins | 1 | 2006 | 52 | 0.060 |
Why?
|
| Escherichia coli | 1 | 2012 | 1032 | 0.060 |
Why?
|
| Serine-Arginine Splicing Factors | 1 | 2025 | 11 | 0.060 |
Why?
|
| Cell Cycle Proteins | 1 | 2010 | 709 | 0.060 |
Why?
|
| Mice, SCID | 2 | 2018 | 615 | 0.060 |
Why?
|
| Founder Effect | 1 | 2025 | 34 | 0.060 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 7239 | 0.060 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2025 | 88 | 0.060 |
Why?
|
| Doxorubicin | 2 | 2018 | 303 | 0.060 |
Why?
|
| Caspase 8 | 1 | 2024 | 24 | 0.050 |
Why?
|
| Algorithms | 2 | 2022 | 1739 | 0.050 |
Why?
|
| Introns | 1 | 2025 | 319 | 0.050 |
Why?
|
| Caspase 1 | 1 | 2024 | 47 | 0.050 |
Why?
|
| Caspase 3 | 1 | 2024 | 141 | 0.050 |
Why?
|
| Polyphenols | 1 | 2023 | 25 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2018 | 1013 | 0.050 |
Why?
|
| RNA Splicing | 1 | 2025 | 254 | 0.050 |
Why?
|
| Haplotypes | 1 | 2025 | 559 | 0.050 |
Why?
|
| Estrogen Receptor Modulators | 1 | 2023 | 39 | 0.050 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2014 | 105 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 2 | 2014 | 403 | 0.050 |
Why?
|
| Pandemics | 2 | 2021 | 1193 | 0.050 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2023 | 85 | 0.050 |
Why?
|
| Hyperplasia | 1 | 2023 | 204 | 0.050 |
Why?
|
| Exons | 1 | 2025 | 839 | 0.050 |
Why?
|
| Aged | 2 | 2021 | 21805 | 0.050 |
Why?
|
| Ubiquitination | 2 | 2013 | 186 | 0.050 |
Why?
|
| Skin | 1 | 2025 | 545 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 3760 | 0.050 |
Why?
|
| Time Factors | 1 | 2012 | 6595 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2021 | 182 | 0.040 |
Why?
|
| Environmental Monitoring | 1 | 2021 | 91 | 0.040 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2021 | 169 | 0.040 |
Why?
|
| Mutation | 3 | 2025 | 6350 | 0.040 |
Why?
|
| GRB10 Adaptor Protein | 1 | 2020 | 6 | 0.040 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 2020 | 17 | 0.040 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2020 | 20 | 0.040 |
Why?
|
| Chromogranins | 1 | 2020 | 29 | 0.040 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2020 | 86 | 0.040 |
Why?
|
| Dioxygenases | 1 | 2020 | 65 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2022 | 385 | 0.040 |
Why?
|
| Urban Population | 1 | 2021 | 244 | 0.040 |
Why?
|
| Ultraviolet Rays | 1 | 2020 | 210 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2025 | 965 | 0.040 |
Why?
|
| GTP-Binding Proteins | 1 | 2020 | 188 | 0.040 |
Why?
|
| Health Surveys | 1 | 2020 | 262 | 0.040 |
Why?
|
| Prognosis | 2 | 2023 | 5084 | 0.040 |
Why?
|
| Carya | 1 | 2018 | 1 | 0.040 |
Why?
|
| Pimozide | 1 | 2018 | 7 | 0.040 |
Why?
|
| Hyperprolactinemia | 1 | 2018 | 22 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 318 | 0.040 |
Why?
|
| Asia | 1 | 2018 | 127 | 0.040 |
Why?
|
| Risperidone | 1 | 2018 | 60 | 0.030 |
Why?
|
| Luminescent Agents | 1 | 2017 | 6 | 0.030 |
Why?
|
| Osteocytes | 1 | 2017 | 14 | 0.030 |
Why?
|
| Selenium | 1 | 2017 | 20 | 0.030 |
Why?
|
| Life Style | 1 | 2020 | 463 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2020 | 488 | 0.030 |
Why?
|
| Fishes | 1 | 2017 | 42 | 0.030 |
Why?
|
| Cities | 1 | 2017 | 51 | 0.030 |
Why?
|
| Zebrafish | 1 | 2020 | 421 | 0.030 |
Why?
|
| Delayed-Action Preparations | 1 | 2017 | 124 | 0.030 |
Why?
|
| Biological Availability | 1 | 2017 | 151 | 0.030 |
Why?
|
| Intestines | 1 | 2021 | 614 | 0.030 |
Why?
|
| Mental Health | 1 | 2020 | 374 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 920 | 0.030 |
Why?
|
| Optical Imaging | 1 | 2017 | 74 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2022 | 1982 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2022 | 771 | 0.030 |
Why?
|
| Breast | 1 | 2018 | 218 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 2 | 2012 | 1434 | 0.030 |
Why?
|
| Glass | 1 | 2016 | 12 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2020 | 417 | 0.030 |
Why?
|
| Risk Factors | 2 | 2023 | 11189 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2017 | 232 | 0.030 |
Why?
|
| Logistic Models | 1 | 2020 | 1908 | 0.030 |
Why?
|
| Antigens, Viral, Tumor | 1 | 2015 | 47 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2016 | 233 | 0.030 |
Why?
|
| Equipment Design | 1 | 2017 | 609 | 0.030 |
Why?
|
| Genes, ras | 1 | 2015 | 102 | 0.030 |
Why?
|
| Alleles | 1 | 2020 | 1724 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 2170 | 0.030 |
Why?
|
| Virus Latency | 1 | 2015 | 64 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2014 | 63 | 0.030 |
Why?
|
| Antipsychotic Agents | 1 | 2018 | 390 | 0.030 |
Why?
|
| Cell Tracking | 1 | 2014 | 17 | 0.030 |
Why?
|
| Virion | 1 | 2015 | 151 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2014 | 103 | 0.030 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2014 | 25 | 0.030 |
Why?
|
| Colony-Forming Units Assay | 1 | 2014 | 69 | 0.030 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2014 | 42 | 0.030 |
Why?
|
| Materials Testing | 1 | 2013 | 77 | 0.030 |
Why?
|
| Etoposide | 1 | 2014 | 120 | 0.030 |
Why?
|
| Disease Progression | 1 | 2020 | 2265 | 0.030 |
Why?
|
| Heterografts | 1 | 2014 | 201 | 0.030 |
Why?
|
| Fluorouracil | 1 | 2014 | 141 | 0.030 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2013 | 15 | 0.030 |
Why?
|
| Prevalence | 1 | 2020 | 2684 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2015 | 371 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 1 | 2013 | 15 | 0.030 |
Why?
|
| Organosilicon Compounds | 1 | 2013 | 2 | 0.030 |
Why?
|
| Colloids | 1 | 2013 | 17 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2020 | 1148 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2014 | 296 | 0.030 |
Why?
|
| Porosity | 1 | 2013 | 44 | 0.030 |
Why?
|
| Caspase 9 | 1 | 2013 | 76 | 0.020 |
Why?
|
| Polypyrimidine Tract-Binding Protein | 1 | 2012 | 12 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2014 | 367 | 0.020 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2012 | 26 | 0.020 |
Why?
|
| Phospholipase C gamma | 1 | 2012 | 29 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 399 | 0.020 |
Why?
|
| Transcription Factor RelA | 1 | 2012 | 57 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2023 | 6612 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 2012 | 123 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2012 | 329 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2014 | 793 | 0.020 |
Why?
|
| Erythrocytes | 1 | 2013 | 234 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2012 | 165 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 1735 | 0.020 |
Why?
|
| Serine | 1 | 2012 | 185 | 0.020 |
Why?
|
| Neoplasm Grading | 1 | 2012 | 308 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 260 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2021 | 3753 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2012 | 651 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2014 | 701 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2021 | 4008 | 0.020 |
Why?
|
| RNA Interference | 1 | 2012 | 548 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2012 | 914 | 0.020 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2010 | 104 | 0.020 |
Why?
|
| Models, Biological | 1 | 2014 | 1538 | 0.020 |
Why?
|
| Kidney | 1 | 2016 | 1404 | 0.020 |
Why?
|
| Keratin-9 | 1 | 2008 | 3 | 0.020 |
Why?
|
| Alpharetrovirus | 1 | 2008 | 5 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2008 | 97 | 0.020 |
Why?
|
| Cell Line | 1 | 2013 | 2863 | 0.020 |
Why?
|
| Cell Transformation, Viral | 1 | 2008 | 99 | 0.020 |
Why?
|
| Glucose | 1 | 2012 | 926 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 3057 | 0.020 |
Why?
|
| HIV | 1 | 2008 | 193 | 0.020 |
Why?
|
| Receptors, Steroid | 1 | 2006 | 276 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2006 | 1051 | 0.010 |
Why?
|